1-(tert-Butoxycarbonyl)-4-methoxypiperidine-4-carboxylic acid

Catalog No. :
ACLORC258
CAS No. :
1082042-29-2
Molecular Formula :
C12H21NO5
Molecular Weight :
259.30

IUPAC Name:1-(tert-butoxycarbonyl)-4-methoxypiperidine-4-carboxylic acid

1-(tert-Butoxycarbonyl)-4-methoxypiperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$65.00Login to see priceIn stockInquiry
1g97%$143.00Login to see priceIn stockInquiry
5g97%$644.00Login to see priceIn stockInquiry
25g97%$2898.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)-4-methoxypiperidine-4-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)-4-methoxypiperidine-4-carboxylic acid
MDL No.MFCD11845557
Molecular FormulaC12H21NO5
Molecular Weight259.30
SMILESO=C(C1(OC)CCN(C(OC(C)(C)C)=O)CC1)O
InChI KeyJPZJLASWSZCENI-UHFFFAOYSA-N
SynonymCS-0052688 | SY038151 | SB15722 | SCHEMBL1146902 | FT-0766276 | 1-(tert-Butoxycarbonyl)-4-methoxypiperidine-4-carboxylicacid | 1-Boc-4-Methoxy-4-Carbocylic acid | 1-Boc-4-methoxypiperidine-4-carboxylic acid | MFCD11845557 | Z600402344 | 1082042-29-2 | 4-M
CAS No.1082042-29-2
PubChem CID45791730

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLORC258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLORC258 route product structure diagram
    ACLORC2581082042-29-2 In Stock
Inquiry

2. ACLORC258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXAPG764 route compound structure diagram
    ACXAPG764495415-08-2 In Stock
  2. Then
  3. ACLORC258 route product structure diagram
    ACLORC2581082042-29-2 In Stock
Inquiry

Comments (0)